bpc-157 human clinical trials status fda warning Regeneration or Risk? A Narrative Review of for Musculoskeletal Healing fda warning bpc-157 unapproved new
Description
Always refer to the reconstitution protocol included with each compound
doi: 10.3390/ijms241813784
2024;16:e51851
Some researchers hypothesize that immunomodulatory peptides could enhance the tolerance-inducing effects of immunotherapy, though this has not been formally studied
